These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7689307)

  • 1. Phenotypic and functional abnormalities of B cells in myasthenia gravis.
    Ragheb S; Lisak RP
    Ann N Y Acad Sci; 1993 Jun; 681():256-63. PubMed ID: 7689307
    [No Abstract]   [Full Text] [Related]  

  • 2. CD5+ B cells in myasthenia gravis. Clinical correlations.
    Ragheb S; Lisak RP
    Ann N Y Acad Sci; 1992 May; 651():586-7. PubMed ID: 1376084
    [No Abstract]   [Full Text] [Related]  

  • 3. [Distribution of B-lymphocyte subgroup CD20 and its clinical significance in patients with myasthenia gravis].
    Zhang Q; Hu Y; Zhang L; Li Y; Yin H; Li J
    Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):239-41. PubMed ID: 11825378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-acetylcholine receptor antibody synthesis by cultured lymphocytes in myasthenia gravis: thymic and peripheral blood cell interactions.
    Newsom-Davis J; Willcox N; Scadding G; Calder L; Vincent A
    Ann N Y Acad Sci; 1981; 377():393-402. PubMed ID: 6978662
    [No Abstract]   [Full Text] [Related]  

  • 5. Levels of CD5+ B lymphocytes do not differ between patients with myasthenia gravis and healthy individuals.
    Yi Q; Ahlberg R; Pirskanen R; Lefvert AK
    Neurology; 1992 May; 42(5):1081-4. PubMed ID: 1374547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities in immunoregulatory CD5+ B cells precede the diagnosis of multiple myeloma.
    Paglieroni T; MacKenzie MR; Caggiano V
    Ann N Y Acad Sci; 1992 May; 651():486-7. PubMed ID: 1376067
    [No Abstract]   [Full Text] [Related]  

  • 7. Selection of autoantibody specificities in the Ly-1 B subset.
    Hayakawa K; Carmack CE; Shinton SA; Hardy RR
    Ann N Y Acad Sci; 1992 May; 651():346-53. PubMed ID: 1376054
    [No Abstract]   [Full Text] [Related]  

  • 8. Thymic B-cell activation in myasthenia gravis.
    Levinson AI; Zweiman B; Lisak RP; Dziarski A; Moskovitz AR
    Neurology; 1984 Apr; 34(4):462-8. PubMed ID: 6608064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disturbed B cell subpopulations and increased plasma cells in myasthenia gravis patients.
    Kohler S; Keil TO; Swierzy M; Hoffmann S; Schaffert H; Ismail M; Rückert JC; Alexander T; Hiepe F; Gross C; Thiel A; Meisel A
    J Neuroimmunol; 2013 Nov; 264(1-2):114-9. PubMed ID: 24099983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The thymus in myasthenia gravis. Evidence for altered cell populations.
    Abdou NI; Lisak RP; Zweiman B; Abrahamsohn I; Penn AS
    N Engl J Med; 1974 Dec; 291(24):1271-5. PubMed ID: 4279335
    [No Abstract]   [Full Text] [Related]  

  • 11. Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis.
    Sims GP; Shiono H; Willcox N; Stott DI
    J Immunol; 2001 Aug; 167(4):1935-44. PubMed ID: 11489973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and cloning of rabbit CD5.
    Raman C; Knight KL
    Ann N Y Acad Sci; 1992 May; 651():78-81. PubMed ID: 1376091
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis.
    Willcox HN; Newsom-Davis J; Calder LR
    Clin Exp Immunol; 1984 Oct; 58(1):97-106. PubMed ID: 6236921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogen and muscle extract induced in vitro proliferative responses in myasthenia gravis, dermatomyositis, and polymyositis.
    Lisak RP; Zweiman B
    J Neurol Neurosurg Psychiatry; 1975 Jun; 38(6):521-4. PubMed ID: 1151419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymic lymphocyte function in myasthenia gravis.
    Armstrong RM; Nowak RM; Falk RE
    Neurology; 1973 Oct; 23(10):1078-83. PubMed ID: 4542653
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and immunologic correlations in myasthenia gravis: measurement of con A stimulated suppressor cell activity.
    Koethe SM; Cook A; McQuillen DP; McQuillen MP
    Ann N Y Acad Sci; 1981; 377():447-54. PubMed ID: 6462092
    [No Abstract]   [Full Text] [Related]  

  • 17. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.
    Fujii Y; Hashimoto J; Monden Y; Ito T; Nakahara K; Kawashima Y
    J Immunol; 1986 Feb; 136(3):887-91. PubMed ID: 2416838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human T cell intrathymic ontogeny: differences between myasthenic and normal thymus.
    Durelli L; Ferrio MF; Massazzá U; Cavallo R; Ferri R; Bergamini L; Maggi G; Casadio C; Poccardi G
    Int J Neurosci; 1990 Apr; 51(3-4):321-3. PubMed ID: 2279894
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative analysis of T and B-cell subpopulations in normal thymus and thymus of myasthenia gravis.
    Wada H; Matsunobe S; Ito M; Teramatsu T
    Bull Chest Dis Res Inst Kyoto Univ; 1980 Mar; 13(1-2):19-24. PubMed ID: 6985458
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of clinical status and treatment on the frequency of CD5+ B cells in patients with myasthenia gravis.
    Ragheb S; Lisak RP
    Neurology; 1992 May; 42(5):1076-80. PubMed ID: 1374546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.